comprehensive -WSS

comprehensive

author：leisure time 2025-09-27 12:23:11 - browse：27

Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： What we need to know about Arena Bioworks

leisure time

WSS

Juul spent big to court Black leaders to promote its e

Cosmetics set for new safety regulation. Why the industry is on board

How dance can help nurses traumatized by Covid

STAT Virtual Event: The State of Biosimilars: What to Watch

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

Cybersecurity threat forces Lurie Children's to take systems offline

knowledge

comprehensive

hotspot

Cancer drug shortages should be causing more outrage

Group opposing PBM reform sets lobbying record

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

New Ultima Genomics DNA sequencer can read genome for $100

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Google and Epic fight stronger regulation of AI in health care

Supreme Court strikes down use of affirmative action

General Catalyst, Summa Health deal will turn on physician buy

Walensky prepares to leave CDC — and Congress — behind

Group opposing PBM reform sets lobbying record

hotspot

Do digital therapeutics have a future in medicine?

AI can’t replace a physician’s gut feeling

FDA drug safety: Singulair case shows systemic surveillance flaws

Commercial surrogacy can be ethical, despite pope’s claims

Some dementia cases could be undiagnosed liver disease

In early work, researchers turn to CRISPR to treat Alzheimer's

focus

leisure time

entertainment

focus